Treatment with a PPAR-γ Agonist Protects Against Hyperuricemic Nephropathy in a Rat Model

PURPOSE: Hyperuricemia is an independent risk factor for renal damage and can promote the progression of chronic kidney disease (CKD). In the present study, we employ a rat model to investigate the effects of rosiglitazone (RGTZ), a peroxisome proliferator-activated receptor-gamma agonist, on the de...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xin, Deng, Jin, Xiong, Chongxiang, Chen, Haishan, Zhou, Qin, Xia, Yue, Shao, Xiaofei, Zou, Hequn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292262/
https://www.ncbi.nlm.nih.gov/pubmed/32606592
http://dx.doi.org/10.2147/DDDT.S247091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292262/
https://www.ncbi.nlm.nih.gov/pubmed/32606592
http://dx.doi.org/10.2147/DDDT.S247091

Ejemplares similares